Patent ID: 7750024

Claim:
A method for treating glioblastoma comprising administering a therapeutically effective amount of a compound having an activity of inhibiting an α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor to a patient with the disease, wherein the compound is [7-(1H-imidazol-1-yl)-6-nitro-2,3-dioxo-3,4-dihydroquinoxalin-1(2H)-yl]acetic acid or a salt thereof; 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline or a salt thereof; 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3,2-e]-1,3-thiazin-4-one or a salt thereof; 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine or a salt thereof, or 7-acetyl-5-(4-aminophenyl)-8(R)-methyl-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine or a salt thereof.